Uterine (Endometrial) Cancer
There are two types of uterine cancer: endometrial cancer and uterine sarcoma. Uterine sarcoma is uncommon and forms in the uterine muscles or tissues. Endometrial cancer is the most common type, and it occurs when malignant cells develop in the lining of the uterus (endometrium).
Every year, more than 66,000 women in the United States are diagnosed with uterine cancer.
Early detection improves the chances that treatment will be successful. If you are experiencing symptoms such as unusual vaginal bleeding, pelvic pain or abnormal vaginal discharge, see your doctor. After an assessment of your symptoms, risk factors and medical history, in addition to a physical and pelvic exam, you may undergo one or more tests to help detect uterine cancer and endometrial cancer.
Several different treatment options are available if you’ve been diagnosed with uterine cancer and endometrial cancer. Our dedicated team of experts takes a patient-centered approach to create a treatment plan based on your specific situation.
City of Hope is a recognized leader in uterine cancer and endometrial cancer research. We offer access to numerous clinical trials and new therapies that are not readily available elsewhere. Our latest research includes developing more precise surgical and radiation techniques for better tumor removal, identifying drugs that can better fight cancer throughout the body, and boosting the quality of life for our patients and survivors.
When you come to City of Hope, you automatically gain access to an unparalleled array of support services to help you and your family take each step during and after your uterine cancer and endometrial cancer treatment.
Our Expertise
City of Hope is a nationally recognized leader in researching and treating gynecological cancers. U.S. News & World Report has named City of Hope one of the top cancer hospitals in America.
Our multidisciplinary staff pursues an integrated approach to treating uterine and endometrial cancer by combining the latest research with outstanding patient care.
Our Endometrial Cancer Program Highlights:
- Innovative, minimally invasive surgical approaches, reducing pain, blood loss and recovery time
- Cytoreductive (debulking) surgery procedures that can improve outcomes
- Highly precise radiation delivery, increasing its effectiveness against cancer while reducing exposure to normal tissues
- Comprehensive diagnostic tools
- Individually customized chemotherapy regimens, including intraperitoneal and heated intraperitoneal chemotherapy
- Fertility-preserving treatment options
City of Hope is one of the few facilities designated a comprehensive cancer center by the National Cancer Institute.
Our developments in the areas of breakthrough cancer drugs, bone marrow transplants and CAR T cell therapy are recognized internationally.
Our leadership in research and innovation continually enhances our ability to provide novel and differentiated approaches to cancer care.
